: iStockAnalyst.com Symbols Feed

BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI

Mon, 16 Nov 2009 15:51:26 GMT

On 11/16/09, Cytori Therapeutics (NASDAQ: CYTX) completed enrollment in a 70-patient, international breast cancer reconstruction study, RESTORE 2. The study is evaluating the use of cell-enriched fat grafting to restore functional and cosmetic deformities in women who have undergone partial mastectomy for early breast cancer. Interim data on the first 32 patients who have reached the six-month follow-up will be presented as a poster at the San Antonio Breast Cancer Symposium on 12/12/0 at 7am (CT) by Mrs. Eva Weiler-Mithoff, MD, lead investigator at the Glasgow Royal Infirmary.[More...]

Emergent BioSolutions Earnings - Blowout Quarter

Fri, 07 Nov 2008 01:42:00 GMT

I almost bought Emergent BioSolutions (EBS) today on the pullback to support (20 day moving average) to fill my 2 stock "government as customers" portfolio - but with earnings tonight I wanted to hold off. And what an earnings they are - EBS should be on Jimmy Cramer's radar any day now as a "buy buy buy". I really like this company because you get a biotech pipeline for the future, thrown on top of a "government as customer" Anthrax business today. Here was our original write up - thanks to whichever reader brought this little gem to our attention. (Oct 22: Readers Idea: Emergent BioSolutions) Total

But the way to lead is not to raise taxes and put more money and power in hands of Washington politicians," Mr. Jindal said during his televised rebuttal.

The Republican Party, desperate for a charismatic leader to help lift it from the political wilderness, picked Mr. Jindal, a young political prodigy who has been frequently mentioned as a potential candidate for the 2012 presidential election.

: iStockAnalyst.com Symbols Feed

BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI

Emergent BioSolutions Earnings - Blowout Quarter

Recession to Push More into Public Health Coverage, Analysts Say

Recession to Push More into Public Health Coverage, Analysts Say

EDITORIAL: Daschle, Others Show Obama Needs to Step Up His Game

Editorials on Tom Daschle

EDITORIAL: Daschle is Dispensable

Daschle is Dispensable

Obama to Name Ex-Senate Leader to Cabinet Ex-Senate Leader Daschle to Serve As HHS Head

Across Systems Sponsors Aberdeen Study on Technical Documentation Translation

Offer Optimization Becomes a Reality: Aberdeen Group Reveals Combination of Technology and Customer Analytics as Keys to Improving Marketing Performance

Top Performers Bank on Customer Analytics to Optimize Marketing Performance

Companies Identify Major Business Benefits in Listening to Online Conversation

BPM Drives Cost and Time Savings for Leading Companies

Incremental Online Process Transformation High on the Agenda for Top Performing Retailers

Boston Red Sox Round Out Final Speaker Lineup for Aberdeen's 4th Annual Chief Service Officer Summit

Online Merchandising Process Transformation High on the Agenda for Top Performing Retailers

Aberdeen Group Announces the 2009 Chief Marketing Officer Summit Final Speaker Lineup

Top Performing Vendors in Sales & Operations Planning Solutions Revealed

Form 4 HARTE HANKS INC For: Nov 30 Filed by: FRANKLIN LARRY (10K)

Form 4 HARTE HANKS INC For: Nov 11 Filed by: HARTE CHRISTOPHER M (10K)

Form 4 HARTE CHRISTOPHER M For: Nov 04 (10K)

Form 4 FRANKLIN LARRY For: Aug 21 (10K)

Form 4 HARTE CHRISTOPHER M For: Jul 01 (10K)

Form 4 FARLEY WILLIAM F For: Jul 01 (10K)

Form 4 GAYDEN WILLIAM For: Jul 01 (10K)

Form 4 GAYDEN WILLIAM For: May 08 (10K)

Form 4 GAYDEN WILLIAM For: Apr 02 (10K)

Form 4 FARLEY WILLIAM F For: Apr 02 (10K)